Outset Medical (NSDQ:OM) CEO Leslie Trigg took the helm at the dialysis start-up in 2013, moving from an executive-in-residence post at private equity firm Warburg Pincus. Before that she held senior positions at Lutonix, AccessClosure and FoxHollow, helping to position those companies to be acquired by CR Bard, Cardinal Health, and ev3/Covidien, respectively. This week, […]
Varian wins FDA clearance for cancer therapy software
Varian Medical Systems (NYSE:VAR) announced that it received FDA 510(k) clearance for its Eclipse v16.1 treatment planning software. Palo Alto, Calif.-based Varian’s Eclipse V16.1 software is designed to enhance the visibility of soft tissue and provide more accurate information about tissue density, allowing dosimetrists to plan more precisely as they go about performing proton therapy, according […]
Varian names new president & COO among other personnel changes
Varian Medical Systems (NYSE:VAR) today announced a trio of personnel changes including the appointment of a new president and COO. Effective Oct. 5, 2020, current Varian Oncology Systems president Chris Toth will take over the newly created roll of president and COO. As a result, current senior VP of global operations Kevin O’Reilly will take over […]
MedTech 100 roundup: Another high as stocks tick up
For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]
Siemens Healthineers to buy Varian for $16.4b
Siemens Healthineers (ETR: SHL) will acquire Varian Medical Systems (NYSE:VAR) in a $16.4 billion deal to create what the companies say will be the most comprehensive cancer care portfolio in the industry. SHL shares closed down –8.95% to €40.02 apiece in trading in Germany today, while VAR shares are up 21.61% to $173.57 apiece as of midday NYSE […]
Varian appoints chief legal officer and interventional solutions president
Varian Medical Systems (NYSE:VAR) this week announced it appointed Michael Hutchingson as SVP and chief legal officer and Francis Facchini as president of interventional solutions. Prior to joining Varian, Hutchinson most recently served as VP and advisor to the chairman and CEO at Stryker. He also previously served as general counsel, VP and chief legal officer […]
Varian launches remote care software for cancer patients
Varian Medical Systems (NYSE:VAR) announced that it launched new capabilities for its Noona software for monitoring cancer patients. Noona supports cancer care teams with patient screening, real-time symptom reporting, secure care team messaging, telephone triage automation and patient access to medical records, enabling continuous reporting and symptom monitoring for cancer patients. Palo Alto, Calif.-based Varian also […]
How will coronavirus affect medtech companies that rely on elective surgeries?
One thing is likely to hurt some medtech companies more than others during the coronavirus pandemic: an elective surgical procedure slowdown. This thought had begun to emerge last week among industry watchers, but a pair of tweets over the weekend gained thousands of “likes” and retweets. The American College of Surgeons called for hospitals to […]
Medical device company stocks aren’t immune from coronavirus
Major U.S. medical device company stocks have generally performed as poorly as others over the past two weeks as the global coronavirus outbreak drive markets down. Among 20 of the largest U.S. companies on Medical Design & Outsourcing and MassDevice‘s annual Big 100 list, both the average and median decline in price was roughly 17% […]
FDA clears Varian’s AI-driven radiation therapy
Varian Medical Systems (NYSE:VAR) announced today that it won FDA 510(k) clearance for its Ethos AI-driven adaptive intelligence solution for cancer care. Ethos is designed to offer an adaptive treatment based on the patient’s anatomy and position to better target the tumor, reduce the dose to healthy tissue and improve overall outcomes within a 15-minute time […]
Varian Medical shares down on Q1 bottom-line slide
Varian Medical (NYSE:VAR) shares dropped today on first-quarter results that came up short of the consensus forecast. The Palo Alto, Calif.–based radiotherapy device maker posted profits of $88.9 million, or 96¢ per share, on sales of $829.9 million for the three months ended Dec. 31, 2019, for a 14.4% bottom-line slide on sales growth of 11.9%. […]
- 1
- 2
- 3
- …
- 16
- Next Page »
